In order to elucidate the underlying molecular mechanism of how RhoE/ROCK2 might regulate HCC chemoresistance, we screened a number of pro-survival signaling pathways and identified JAK2/STAT3 as a candidate. Here, JAK2 is linked to hepatocellular carcinoma.